Download 2007 Analysis of 15 years of skin cancer in central Iran

yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Analysis of 15 years of skin cancer in central Iran (Yazd)
Mohammad Taghi Noorbala MD, P Kafaie MD
Dermatology Online Journal 13 (4): 1
Dermatology Department, Shahid Sadoughi Medical Science University of Yazd, Iran.
[email protected]
Skin cancer incidences over a 15-year period (1987-2001) were studied in Yazd, a hot, dry, desert area in
the center of Iran. The mean skin cancer frequency was determined to be 28.6 percent and 1,124
patients were diagnosed with skin cancer during this time period, approximately 11 per 100,000. The
most common skin cancer was basal cell carcinoma, accounting for 76.9 percent. Squamous cell
carcinoma was diagnosed in 18.1 percent and melanoma in 2.7 percent; 2.3 percent were other
uncommon skin cancers. Most cancers were diagnosed in the seventh and eighth decades of life. The
face, head, and neck were the sites of 92 percent of skin cancers. The sex ratio was determined to be 1.6
(male/female), similar to other reported populations. However, melanoma was found to be 1.5 times
higher in men in this study, in contrast to most studied populations. Skin cancer incidence in Iran is lower
than western countries. It is very likely that clothing and body covering customs can account for such
Skin cancer is one of the most common cancer types in most countries. Skin cancers are usually visible if
full skin examinations are performed. If sufficient basic information is given to patients and if physicians
and medical students are trained comprehensively, most skin cancers can be diagnosed and treated with
minimal costs and facilities [1, 2, 3, 4].
Skin cancer is most often attributed to solar ultraviolet exposure. In tropical countries, those who work
outdoors during daytime and those with light skin are more likely to develop skin malignancies [5]. The
frequency of skin cancer cases increases with age [6].
In Iran, because of the bright sunlight during most seasons and the direct exposure to the sun of farmers,
animal herders, sailors, and construction workers, along with the uncommon use of suitable protective
apparel and hats, higher incidences of skin cancer can be expected. Studies of skin cancers within the
country have shown a variety of results [7, 8, 9].
This is a cross-sectional descriptive study using simple census sampling. The sample population consists
of patients who have been referred to Yazd Province's health centers between 1987 and 2001 and
diagnosed with cancer by the pathology departments. We used data from the cancer registry center of the
province for performing this study. Yazd is a province with a population of one million that is located in a
relatively warm and dry desert area in the center of the Islamic Republic of Iran.
During the study period, skin cancer reports were collected along with general information including age,
sex, occupation, residence, cancer location and type (pathology). Non-skin cancers were recorded as to
their types and, for ease of presentation, only the six most common cancer types are reported.
We have divided common skin cancers into the three main categories of basal cell carcinoma (BCC),
squamous cell carcinoma (SCC), and malignant melanoma; the other reported non-common skin
cancers, which were of six types, were recorded as miscellaneous.
A total of 3,930 patients with cancer between 1987 and 2001 was reported. Skin cancer with a mean
frequency of 28.6 percent over the 15-year study period, was the most commonly reported cancer; 1,124
were diagnosed (Fig. 1). Of these skin cancers, 76.9 percent were BCC, 18.1 percent were SCC, 2.7
percent were malignant melanoma, and 2.3 percent were other less common skin cancers (Fig. 2).
Table 1 shows the frequency distribution of skin cancers according to gender, and as has been
demonstrated, skin cancer among men is reported 1.6 times higher than women (61.7 % men and 38.3 %
women). Many of the skin cancers in women were noted in the seventh and eighth decades of life.
Table 2 shows the frequency distribution according to age, with 6 age groups studied. The highest
frequency of BCC was within the 60-69 year-old group (23.6 %) and SCC within the 70-79 year-old group
(22 %). Malignant melanoma occurred most frequently in the 60-69 year-age group (26.7 %).
Table 3 shows the frequency distribution according to occupation. In most instances the highest rate of
skin cancer was noted in farmers (22 %).
Table 4 shows the frequency distribution according to the location of the cancer on the body. The facial
area alone comprises 71.7 percent of all cases. Overall, 92 percent of all skin cancers occurred in the
face, head and neck regions.
Epidemiological studies of skin cancers have been carried out across the globe, and the majority of them
have reported that skin cancers represent about 20-40 percent of all cancer types [1, 2, 3, 4]. In the
United States it is estimated that there are more than one million annual cases of skin cancer [10]. The
occurrence rate of skin cancer within the U.S. population is about 300-400 new cases for every 100,000
population per annum [1, 11, 12, 13, 14]. In the United Kingdom, the rate of occurrence is about 100 for
every 100,000 per year. The highest numbers relate to Oceania with roughly 800 new cases for every
100,000 people in a year [1, 15]. There are limited studies in Iran, which have estimated the occurrence
rate of skin cancers at 10 to 15 new cases per 100,000 population [7, 8, 9]. In the present study, we note
approximately 11 new cases of skin cancer per 100,000.
In the United States, Europe, and Australia about 20-25 percent, 20 percent, and 40-45 percent,
respectively, of all reported cancers per year are skin cancers [1, 2, 3, 4, 11, 15, 16, 17].
In the present study in Yazd Province, 28.6 percent of all cancers reported are skin cancers. The most
common skin cancer is BCC, and in the majority of studies conducted in the United States and Australia,
BCC alone comprises around 75 percent and 79 percent, respectively, of all skin cancers [1, 2, 12,14, 15,
17]. A study conducted in Isfahan in 1988 found BCC to make up about 74 percent of skin cancers [7],
and a 1991 study in Yazd reported 76 percent [8]. In the present study, nearly 77 percent of skin cancers
are BCC.
Skin cancers occur mainly in the sixth, seventh, and later decades of life [1, 2, 14, 15, 17]. In the present
study, nearly 70 percent of reported cases of cancer relate to the sixth and later decades. It is important
to mention that malignant melanoma has often been observed in lower age groups, the present study
also shows a 10 year earlier incidence.
Skin cancers occur mainly in sun-exposed regions, and in the face and neck areas of the body [1, 5, 14,
15]. This study shows that more than 90 percent of reported skin cancers were found in the head and
neck regions, which demonstrates the major influence of sunshine on the development of skin cancers.
The frequency of skin cancers in men and women is different. Prior statistics concerning non-melanoma
cancers show the incidence in men to be about 1.5 times higher than in women [6, 14, 15, 17]. The
present study shows a similar non-melanoma skin cancer ratio with men 1.6 times higher than women.
However, melanoma, which is more common among women in other populations, was shown to be 1.5
times higher in men in this study. The 1988 Isfahan study also showed that melanoma was 1.5 times
more frequent in men than in women [8]. It is very likely that clothing and body covering customs, and the
lower levels of employment of women outside the home in Iran may account for such differences.
Ultimately skin cancer incidence in Iran is lower than western countries, although we still estimate that 710 thousand new cases of skin cancer occur in Iran each year. Differences in skin cancer incidence
among populations relate to genetic factors, skin type, societal customs (including clothing and body
coverings), and cultural issues and habits. It is interesting to see these factors operating in such
comparisons between Iran and many other countries, particularly in the sex ratios noted in melanoma.
Such comparisons may help us to identify key issues to address in public health education.
1. Mackie RM, Quinn AG. Non melanoma skin cancer and other epidermal skin tumors. In Textbook of
Dermatology. Burns T, Breathnach S,Cox N (eds), 7 th ed., vol 3, USA Blackwell Scientific Publications,
2. Carucci JA, Leffell DJ. Basal Cell Carcinoma. In Fitzpatrick,s dermatology in general medicine.
Freedberg IM,Eisen AZ (eds ), 6 th ed, V1, USA: Mcgraw-hill 2003; Ch 81.
3. Grossman D, Leffell DJ. Squamous Cell Carcinoma. In Fitzpatrick's dermatology in general medicine.
Freedberg IM, Eisen AZ (eds ), 6 th ed, V1, USA: Mcgraw-hill 2003; Ch 80.
4. Langely RG,Barnhill RL, et al. Cutaneous Melanoma. In Fitzpatrick's dermatology in gerneral medicine.
Freedberg IM,Eisen AZ (eds ), 6 th ed, V1, USA: Mcgraw-hill 2003; Ch93.
5. Farmer KC, Naylor MF. Sun exposure, sunscreens, and skin cancer prevention: a year-round concern.
Ann Pharmacother. 1996 Jun;30(6):662-73. PubMed
6. Demers AA, Nugent Z, Mihalcioiu C, Wiseman MC, Kliewer EV. Trends of nonmelanoma skin cancer
from 1960 through 2000 in a Canadian population. J Am Acad Dermatol. 2005 Aug;53(2):320-8. PubMed
7. Asilian A, Hasanpour E, et al. Skin cancer evaluation in center of Iran. Pejoohesh in medical science
journal 1998;2:65-67.
8. Noorbala MT, Taheri G. Skin cancer prevalence in Yazd. Nabz journal 1995;8:15-20
9. Iraji F, Arbaby N, Asilian A, et al. Incidence of non-melanoma skin cancers in Isfahan. Iranian J of
Dermatology 2007;38:330-34
10. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J
Clin. 2006 Mar-Apr;56(2):106-30. PubMed
11. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among
whites in the United States. J Natl Cancer Inst. 2001 May 2;93(9):678-83. PubMed
12. Geller AC, Zhang Z, Sober AJ, Halpern AC, Weinstock MA, Daniels S, Miller DR, Demierre MF,
Brooks DR, Gilchrest BA. The first 15 years of the American Academy of Dermatology skin cancer
screening programs: 1985-1999.J Am Acad Dermatol. 2003 Jan;48(1):34-41. PubMed
13. Heymann WR. Skin cancer in African Americans. J Am Acad Dermatol. 2005 Sep;53(3):485-6.
14. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad
Dermatol. 1994 May;30(5 Pt 1):774-8. PubMed
15. Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J
(Clin Res Ed). 1988 Jan 2;296(6614):13-7. PubMed
16. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001 Mar 29;344(13):975-83.
17. Kennedy C, Bajdik CD. Descriptive epidemiology of skin cancer on Aruba: 1980-1995. Int J Dermatol.
2001 Mar;40(3):169-74. PubMed